PLGA-Based Polymeric Nanoparticles for Voglibose Delivery in Antidiabetic Therapy
Diabetes mellitus is a chronic metabolic disorder requiring innovative therapeutic approaches. Voglibose, an effective α-glucosidase inhibitor, has limitations, including low solubility and a short duration of action when taken as a tablet. Polymeric nanoparticles, particularly PLGA (Poly-lactic-co-glycolic acid),...